The Hexion transaction was deemed to be a superior proposal to the Basell
agreement and was unanimously approved by the Board of Directors of Huntsman.
It is subject to regulatory approval in the United States and Europe, approval
of Huntsman shareholders, and customary closing conditions. Entities who
collectively own approximately 57% of Huntsman's common stock, have agreed to
vote in favor of the transaction.